• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Contribution of dsRNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I IFN Production and Activation of Human Dendritic C

tetano

Editor, Senior Moderator
J Virol. 2012 Dec 19. [Epub ahead of print]
Contribution of dsRNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I IFN Production and Activation of Human Dendritic Cells.
Ramos I, Carnero E, Bernal-Rubio D, Seibert CW, Westera L, Garc?a-Sastre A, Fernandez-Sesma A.
Source

Department of Microbiology.
Abstract

The influenza virus NS1 protein inhibits innate immunity by multiple mechanisms. We previously reported that NS1 is able to inhibit the production of type I IFN and the production of pro-inflammatory cytokines in human primary dendritic cells (DCs). Here, we used recombinant viruses expressing mutant NS1 from A/Texas/36/91 and A/Puerto Rico/08/34 strains in order to analyze the contribution of different NS1 domains to its antagonist functions. We show that the CPSF30 binding function of the NS1 protein from A/Texas/36/91 influenza virus, which is absent in the A/Puerto Rico/08/34 strain, is essential for counteracting these innate immune events in DCs. However, the dsRNA binding domain, present in both strains, specifically inhibits induction of type I IFN genes in infected DCs. While it is only essential for inhibition of type I IFN proteins and pro-inflammatory cytokine production in cells infected with influenza viruses lacking a functional CPSF30 binding domain, such as A/Puerto Rico/08/34.

PMID:
23255794
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23255794
 
Back
Top